The market for weight-loss drugs is projected to be worth around US$130 billion by 2030, which would require an annual growth of nearly 50% from todays levels
107 Moreover, hormone-sensitive tissues such as the breast, endometrium, and prostate also exhibit significant metabolic fluctuations in response to hormone levels
By 2023, this ratio had changed to 40% in the public system versus 60% in the private system (Figure 1B)
Its primary applications include: Treatment and Prevention of B Vitamin Deficiencies: This is the most common indication
Continuous hyperserotonemia in Sert / mice, which was 2-fold higher than controls, produced smaller placentas, marked cell death, and necrotic lesions that were similar to placentas from HDP women (257)